Trace elements and cytokine profile in cytomegalovirus-infected pregnancies: A controlled study

Gynecologic and Obstetric Investigation

Volumn 65, Issue 2, 2008, Pages 128-132

  Zhang, Jian Ping ^a   Li, Fen ^a   Yu, Xue Wen ^a   Sheng, Qiu ^a   Shi, Xiao Wei ^a   Zhang, Xin Wen ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Essential trace elements; Human cytomegalovirus; Interleukin 6; Tumor necrosis factor

Indexed keywords

COPPER; CYTOKINE; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 6; IRON; SELENIUM; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ADULT; ARTICLE; BREAST MILK; CHINA; CYTOMEGALOVIRUS INFECTION; ECONOMIC ASPECT; EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MENTAL DEFICIENCY; NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; URINALYSIS; VERTICAL TRANSMISSION; VIRUS DETECTION;

ADULT; ANTIBODIES, VIRAL; CHINA; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; IMMUNOGLOBULIN M; INCIDENCE; INFANT, NEWBORN; INTERLEUKIN-6; MALE; MENTAL RETARDATION; MILK, HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; TRACE ELEMENTS; TUMOR NECROSIS FACTOR-ALPHA; ZINC;

EID: 40349096551     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110013     Document Type: Article

References (32)

1. Hagay ZJ, Biran G, Ornog A, Reece EA: Congenital cytomegalovirus infection: a long-standing problem still seeking a solution. Am J Obstet Gynecol 1996;174:241-245.
2. Raynor BD: Cytomegalovirus infection in pregnancy. Semin Perinatol 1993;17:394-402.
3. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM: Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002;57:245-256.
4. Yan H, Ma XF, Feng ZH: Affecting factors of the prevalence of mental retardation in the Qin-ba mountain area in South Shanxi. J Xian Jiaotong Univ (Med Sci) 1990;3:87-89.
5. Bodeus M, Feyder S, Goubau P: Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infections in pregnant women. Clin Diagn Virol 1998;9:9-16.
6. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, Dussaix E: Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997;175:944-946.
7. Lang D, Vornhagen R, Rothe M, Hinderer W, Sonneborn HH, Plachter B: Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers. Clin Diagn Lab Immunol 2001;8:747-756.
8. Kawada J, Kimura H, Ito Y, Ando Y, Tanaka-Kitajima N, Hayakawa M, Nunoi H, Endo F, Morishima T: Evaluation of systemic inflammatory responses in neonates with herpes simplex virus infection. J Infect Dis 2004;190:494-498.
9. Beaman MH, Hunter CA, Remington JS: Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-γ and TNF-α. J Immunol 1994;153:4583-4587.
10. Wen LZ, Wu SM, Lv SM, Wang ZX, Zeng WJ, Qian XH, Ao LM, Liu LQ, Ling XZ: The epidemiological study on of pregnant women and the maternal fetal transmission in three Chinese metropoles. Chin J Obstet Gynecol 1996;31:714-717.
11. Fang F: Human cytomegalovirus infection and maternal fetal transmission. Chin J Pract Pediatr 2004;19:195-197.
12. Noyola DE, Mejia-Elizondo AR, Canseco-Lima JM, Allende-Carrera R, Hernánsez-Salinas AE, Ramírez-Zacarías JL: Congenital cytomegalovirus infection in San Luis Potosi, Mexico. Pediatr Infect Dis J 2003;22:89-90.
13. Yamamoto AY, Mussi-Pinhata MM, Cristina P, Pinto G, Moraes Figueiredo LT, Jorge SM: Congenital cytomegalovirus infection in preterm and full-term newborn infants from a population with a high seroprevalence rate. Pediatr Infect Dis J 2001;20:188-192.
14. Fowler KB, Stagno S, Pass RF: Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis 1993;168:552-556.
15. Dworsky M, Yow M, Stagno S, Pass RF, Alford C: Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics 1983;72:295-299.
16. Vochem M, Hamprecht K, Jahn G, Speer CP: Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 1998;17:53-58.
17. Forsgren M: Cytomegalovirus in breast milk: reassessment of pasteurization and freeze-thawing. Pediatr Res 2004;56:526-528.
18. Hamprecht K, Maschmann J, Muller D, Dietz K, Besenthal I, Goelz R, Middeldorp JM, Speer CP, Jahn G: Cytomegalovirus inactivation in breast milk: reassessment of pasteurization and freeze-thawing. Pediatr Res 2004;56:529-535.
19. Curtis N, Chau L, Garland S, Tabrizi S, Alexander R, Morley CJ: Cytomegalovirus remains viable in naturally infected breast milk despite being frozen for 10 days. Arch Dis Child Fetal Neonatal Ed 2005;90:F529-F530.
20. Cuevas LE; Koyanagi A: Zinc and immunity: a review. Ann Trop Paediatr 2005;25:149-160.
21. Truong-Tran AQ, Ho LH, Chai F, Zalewski PD: Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J Nutr 2000;130:1459-1466.
22. Shankar AH, Prasad AS: Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin 1998;68:447-463.
23. Glaser W, Triendl A, Skern T: The processing of eIF4GI by human rhinovirus type 2 2A(pro): relationship to self-cleavage and role of zinc. J Virol 2003;77:5021-5025.
24. Rahbar A, Boström L, Lagerstedt U, Magnusson I, Söderberg- Naucler C, Sundqvist VA: Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis 2003;9:154-161.
25. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW: Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003;77:4588-4596.
26. Gealy C, Denson M, Humphreys C, McSharry B, Wilkinson G, Caswell R: Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus. J Virol 2005;79:472-485.
27. Carlquist JF, Edelman L, Bennion DW, Anderson JL: Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-κB. J Infect Dis 1999;179:1094-1100.
28. Orange JS, Wang B, Terhorst C, Biron CA: Requirement for natural killer cell-produced interferon-γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin-12 administration. J Exp Med 1995;182:1045-1056.
29. Geist LJ, Hopkins HA, Dai LY, He B, Monick MM, Hunninghake GW: Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-α promoter. Am J Respir Cell Mol Biol 1997;16:31-37.
30. Haagmans BL, Stals FS, van der Meide PH, Bruggeman CA, Horzinek MC, Schijns VE: Tumor necrosis factor-α promotes replication and pathogenicity of rat cytomegalovirus. J Virol 1994;68:2297-2304.
31. Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk HD, Krüger DH: Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNF-α is mediated via induction of NF-κB. Virology 1995;208:197-206.
32. Ritter T, Brandt C, Prösch S, Vergopoulos A, Vogt K, Kolls J, Volk HD: Stimulatory and inhibitory action of cytokines on the regulation of CMV-IE promoter activity in human endothelial cells. Cytokine 2000;12:1163-1170.